<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03351270</url>
  </required_header>
  <id_info>
    <org_study_id>NatHis-CNM</org_study_id>
    <nct_id>NCT03351270</nct_id>
  </id_info>
  <brief_title>Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies</brief_title>
  <acronym>NatHis-CNM</acronym>
  <official_title>Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Myologie, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dynacure</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut de Myologie, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is the 2 years extension of the prospective and longitudinal study of the natural&#xD;
      history and functional status of patients with myotubular myopathy and other centronuclear&#xD;
      (CNM) sponsored by Dynacure including ten additional pediatric patients with mutation in MTM1&#xD;
      or DNM2 genes). the patients are planned to be enrolled in one year leading to an expected&#xD;
      total number of 70 patients followed at least over 1 year period. Data from the study will be&#xD;
      used to characterize the disease course of CNM and determine which outcome measures will be&#xD;
      the best to assess the efficacy of potential therapies.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 28, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MFM score change from baseline</measure>
    <time_frame>Baseline, 6 months, 12 months and every year up to 60 months</time_frame>
    <description>Motor Function Measure scale. The total test score can range from 0 if the subject cannot perform any of the items to 100 if all the items are fully achieved.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CHOP-INTEND score change from baseline</measure>
    <time_frame>Baseline, 6 months, 12 months and every year up to 60 months</time_frame>
    <description>Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Modified Hammersmith score change from baseline</measure>
    <time_frame>Baseline, 6 months, 12 months and every year up to 60 months</time_frame>
    <description>Modified Hammersmith Functional Motor Scale. The total test score can range from 0 if the subject cannot perform any of the items to 40 if all the items are fully achieved</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Moviplate score change from baseline</measure>
    <time_frame>Baseline, 6 months, 12 months and every year up to 60 months</time_frame>
    <description>Moviplate score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>6MWD change from baseline</measure>
    <time_frame>Baseline, 6 months, 12 months and every year up to 60 months</time_frame>
    <description>6 Minute Walking Distance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Grip strength change from baseline</measure>
    <time_frame>Baseline, 6 months, 12 months and every year up to 60 months</time_frame>
    <description>MyoGrip</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pinch strength change from baseline</measure>
    <time_frame>Baseline, 6 months, 12 months and every year up to 60 months</time_frame>
    <description>MyoPinch</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forced Vital Capacity change from baseline</measure>
    <time_frame>Baseline, 6 months, 12 months and every year up to 60 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Peak Cough Flow change from baseline</measure>
    <time_frame>Baseline, 6 months, 12 months and every year up to 60 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum Inspiratory Pressure change from baseline</measure>
    <time_frame>Baseline, 6 months, 12 months and every year up to 60 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximum Expiratory Pressure change from baseline</measure>
    <time_frame>Baseline, 6 months, 12 months and every year up to 60 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Centronuclear Myopathy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standardized strength, respiratory and motor function assessments</intervention_name>
    <description>Standardized assessments will be adjusted by the age, the ambulant status and the respiratory status of the patient. The visit frequency will also be adjusted according to the age and to the time spent in the study varying between quarterly to yearly.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients of any age (newborns included) may participate&#xD;
&#xD;
          -  Patients over 18 years of age and parent(s)/legal guardian(s) of patients &lt; 18 years&#xD;
             of age must be provide written informed consent prior to participating in the study&#xD;
             and informed assent will be obtained from minors at least 7 years of age when required&#xD;
             by regulation.&#xD;
&#xD;
          -  Myotubular Centronuclear myopathy (MTMCNM) resulting from a mutation in the MTM1, DNM2&#xD;
             or BIN1 gene&#xD;
&#xD;
          -  Male or symptomatic female. A symptomatic female will be defined by the motor function&#xD;
             assessment by Motor Function Measure (MFM) or North Star Ambulatory Assessment (NSAA)&#xD;
             below 80% of the total score.&#xD;
&#xD;
          -  Willing and able to comply with all protocol requirements and procedures.&#xD;
&#xD;
          -  In France only: Affiliated to or a beneficiary of a social security category&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other disease which may significantly interfere with the assessment of the MTM CNM and&#xD;
             is clearly not related to the disease&#xD;
&#xD;
          -  Currently enrolled in a treatment study; or treatment with an experimental therapy&#xD;
             other than pyridostigmine&#xD;
&#xD;
          -  For women: pregnancy or current breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent Servais, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de référence neuromusculaire, CHR La Citadelle; 4000 Liege Belgium</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emmanuelle Lagrue, MD</last_name>
    <phone>+33 1 44 73 65 44</phone>
    <email>e.lagrue@institut-myologie.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre de référence neuromusculaire, CHR La Citadelle</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Servais, MD</last_name>
      <email>Secretariat.crmn@chrcitadelle.belle.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Femme Mère Enfant, CHU Lyon L'Escale</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carole Vuillerot, MD</last_name>
      <email>carole.vuillerot@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Roger Salengro, CHU Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Baptiste Davion, MD</last_name>
      <email>Jeanbaptiste.DAVION@CHRU-LILLE.FR</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Croix Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carole Vuillerot, MD</last_name>
      <email>carole.vuillerot@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Armand Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnaud Isapof, MD</last_name>
      <email>arnaud.isapof@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>I-Motion Institute - Trousseau Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Duchene</last_name>
      <email>d.duchene@institut-myologie.org</email>
    </contact>
    <contact_backup>
      <last_name>Virginie Chê</last_name>
      <email>v.che@institut-myologie.org</email>
    </contact_backup>
    <investigator>
      <last_name>Andreea Seferian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Myology</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Duchene</last_name>
      <email>d.duchene@institut-myologie.org</email>
    </contact>
    <contact_backup>
      <last_name>Virginie Chê</last_name>
      <email>v.che@institut-myologie.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hôpital Sainte Musse</name>
      <address>
        <city>Toulon</city>
        <zip>83056</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel Arnal, MD</last_name>
      <email>Jean-Michel.Arnal@ch-toulon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen (AöR)</name>
      <address>
        <city>Essen</city>
        <zip>D-45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrike Schara, MD</last_name>
      <email>ulrike.schara@uk-essen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bambino Gesu Children's Hospital</name>
      <address>
        <city>Roma</city>
        <zip>00146</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adele D'Amico, MD</last_name>
      <email>adele2.damico@opbg.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Puerta del Mar</name>
      <address>
        <city>Cadiz</city>
        <zip>21-11009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arturo Hernandez</last_name>
      <email>artucadiz@ono.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 14, 2017</study_first_submitted>
  <study_first_submitted_qc>November 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2017</study_first_posted>
  <last_update_submitted>November 23, 2020</last_update_submitted>
  <last_update_submitted_qc>November 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CNM</keyword>
  <keyword>XLMTM</keyword>
  <keyword>Myotubular myopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Diseases</mesh_term>
    <mesh_term>Myopathies, Structural, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

